Mycotoxins nivalenol and deoxynivalenol differentially modulate cytokine mRNA expression in Jurkat T cells

Cytokine

Volumn 36, Issue 1-2, 2006, Pages 75-82

  Severino, Lorella ^a   Luongo, Diomira ^a,b   Bergamo, Paolo ^b   Lucisano, Antonia ^a   Rossi, Mauro ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

Deoxynivalenol; Immunotoxicity; Jurkat T cells; Nivalenol

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 8; IONOMYCIN; MESSENGER RNA; MYCOTOXIN; NIVALENOL; PHORBOL 13 ACETATE 12 MYRISTATE; VOMITOXIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CEREAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; METABOLITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

CELL SURVIVAL; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; JURKAT CELLS; MYCOTOXINS; RNA, MESSENGER; TRICHOTHECENES;

FUSARIUM;

EID: 33846001368     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.11.006     Document Type: Article

References (35)

1. Schothorst R.C., and van Egmond H.P. Report from SCOOP task 3.2.10 "Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states". Subtask: trichothecenes. Toxicol Lett 153 (2004) 133-143
2. Grove J.F. Non-macrocyclic trichothecenes. Nat Prod Rep 5 (1988) 187-209
3. + cells. Food Chem Toxicol 32 (1994) 1125-1136
4. Kidd M.T., Hagler Jr. W.M., and Qureshi M.A. Trichothecene mycotoxins depress the mononuclear-phagocytic system of young turkeys. Immunopharmacol Immunotoxicol 17 (1995) 385-398
5. Rotter B.A., Prelusky D.B., and Pestka J.J. Toxicology of deoxynivalenol (vomitoxin). J Toxicol Environ Health 48 (1996) 1-34
6. Li M., Cuff C.F., and Pestka J. Modulation of murine host response to enteric reovirus infection by the trichothecene deoxynivalenol. Toxicol Sci 87 (2005) 134-145
7. Choi C.Y., Nakajima-Adachi H., Kaminogowa S., and Sugita-Konishi Y. Nivalenol inhibits total and antigen-specific IgE production in mice. Toxicol Appl Pharmacol 165 (2000) 94-98
8. Bondy G.S., and Pestka J.J. Immunomodulation by fungal toxins. J Toxicol Environ Health B Crit Rev 3 (2000) 109-143
9. Forsell J.H., and Pestka J.J. Relation of 8-ketotrichothecene and zearalenone analog structure to inhibition of mitogen-induced human lymphocyte blastogenesis. Appl Environ Microbiol 50 (1985) 1304-1307
10. Thuvander A., Wikman C., and Gadhasson I. In vitro exposure of human lymphocytes to trichothecenes: individual variation in sensitivity and effects of combined exposure on lymphocyte function. Food Chem Toxicol 37 (1999) 639-648
11. Meky F.A., Hardie L.J., Evans S.W., and Wild C.P. Deoxynivalenol-induced immunomodulation of human lymphocyte proliferation and cytokine production. Food Chem Toxicol 39 (2001) 827-836
12. + T cells. Toxicol Appl Pharmacol 140 (1996) 328-336
13. Rocha O., Ansari K., and Doohan F.M. Effects of trichothecene mycotoxins on eukaryotic cells: a review. Food Addit Contam 22 (2005) 369-378
14. Shifrin V.I., and Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem 274 (1999) 13985-13992
15. Ueno Y. Toxicological features of T-2 toxin and related trichothecenes. Fund Appl Toxicol 4 (1984) S124-S132
16. Corrier D.E. Mycotoxicosis: mechanisms of immunosuppression. Vet Immunol Immunopathol 30 (1991) 73-87
17. Iordanov M.S., Pribnow D., Magun J.L., Dinh T.H., Pearson J.A., Chen S.L., et al. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol Cell Biol 17 (1997) 3373-3381
18. Pestka J.J., Uzarski R.L., and Islam Z. Induction of apoptosis and cytokine production in the Jurkat human T cells by deoxynivalenol: role of mitogen-activated protein kinases and comparison to other 8-ketotrichothecenes. Toxicology 206 (2005) 207-219
19. Tajima O., Schoen E.D., Feron V.J., and Groten J.P. Statistically designed experiments in a tiered approach to screen mixtures of Fusarium mycotoxins for possible interactions. Food Chem Toxicol 40 (2002) 685-695
20. Luongo D., Bergamo P., and Rossi M. Effects of conjugated linoleic acid on growth and cytokine expression in Jurkat T cells. Immunol Lett 90 (2003) 195-201
21. Hamalainen H.K., Tubman J.C., Vikman S., Kyrola T., Ylikoski E., Warrington J.A., et al. Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. Anal Biochem 299 (2001) 63-70
22. Tipton D.A., Lyle B., Babich H., and Dabbous M.K. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol in Vitro 17 (2003) 301-310
23. Luongo D., Severino L., Bergamo P., De Luna R., Lucisano A., and Rossi M. Interactive effects of fumonisin B1 and α-zearalenol on proliferation and cytokine expression in Jurkat T cells. Toxicology in vitro 20 (2006) 1403-1410
24. Lepschy-v Gleissenthal J., Dietrich R., Martlbauer E., Schuster M., Suss A., and Terplan G. A survey on the occurrence of Fusarium mycotoxins in Bavarian cereals from the 1987 harvest. Z Lebensm Unters Forsch 188 (1989) 521-526
25. Astoul E., Edmunds C., Cantrell D.A., and Ward S.G. PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models. Trends Immunol 22 (2001) 490-496
26. Li S., Ouyang Y., Yang G.H., and Pestka J.J. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol). Toxicol Appl Pharmacol 163 (2000) 17-25
27. Li S., Ouyang Y.L., Dong W., and Pestka J.J. Superinduction of IL-2 gene expression by vomitoxin (deoxynivalenol) involves increased mRNA stability. Toxicol Appl Pharmacol 147 (1997) 331-342
28. Massarotti E.M., Liu N.Y., Mier J., and Atkins M.B. Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy. Am J Med 92 (1992) 693-697
29. Richards J.M., Mehta N., Ramming K., and Skosey P. Sequential chemoimmunotherapy in the treatment of metastatic melanoma. J Clin Oncol 10 (1992) 1338-1343
30. Chen C.Y., Del Gatto-Konczak F., Wu Z., and Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 280 (1998) 1945-1949
31. Eskola M., Parikka P., and Rizzo A. Trichothecenes, ochratoxin A and zearalenone contamination and fusarium infection in Finnish cereal samples in 1998. Food Addit Contam 18 (2001) 707-718
32. Azcona-Olivera J.I., Ouyang Y.L., Warner R.L., Linz J.E., and Pestka J.J. Effects of vomitoxin (deoxynivalenol) and cycloheximide on IL-2, 4, 5 and 6 secretion and mRNA levels in murine CD4+ cells. Food Chem Toxicol 33 (1995) 433-441
33. Yang G.H., Jarvis B.B., Chung Y.J., and Pestka J.J. Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation. Toxicol Appl Pharmacol 164 (2000) 149-160
34. Nagase M., Alam M.M., Tsushima A., Yoshizawa T., and Sakato N. Apoptosis induction by T-2 toxin: activation of caspase-9, caspase-3, and DFF-40/CAD through cytosolic release of cytochrome c in HL-60 cells. Biosci Biotechnol Biochem 65 (2001) 1741-1747
35. Nasri T., Bosch R.R., Voorde S.T., and Fink-Gremmels J. Differential induction of apoptosis by type A and B trichothecenes in Jurkat T-lymphocytes. Toxicol In Vitro 20 (2006) 832-840